BDX — Becton Dickinson and Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Becton Dickinson and Co, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	R2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	19,131	18,870	19,372	20,178	21,840
Cost of Revenue
Gross Profit	8,687	8,603	8,823	9,163	10,023
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	17,059	16,579	17,202	17,755	19,275
Operating Profit	2,072	2,291	2,170	2,423	2,565
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,692	1,783	1,662	2,005	1,881
Provision for Income Taxes
Net Income After Taxes	1,604	1,635	1,530	1,705	1,678
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	2,092	1,779	1,484	1,705	1,678
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,002	1,689	1,424	1,705	1,678
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	8.6	8.8	6.85	7.91	8.77
Dividends per Share